| Line 15: | Line 15: | ||
<a>Project</a> | <a>Project</a> | ||
<ul class="sub-nav"> | <ul class="sub-nav"> | ||
| − | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/ | + | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/Description">Overview</a></li> |
<li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/projectBP">Benzo[A]Pyrene</a></li> | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/projectBP">Benzo[A]Pyrene</a></li> | ||
<li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/projectcopper">Copper</a></li> | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/projectcopper">Copper</a></li> | ||
| Line 24: | Line 24: | ||
</ul> | </ul> | ||
</li> | </li> | ||
| − | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/ | + | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/Design">Product</a></li> |
| − | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/ | + | <li class="list-item has-sub-nav"> |
| + | <a>Parts</a> | ||
| + | <ul class="sub-nav"> | ||
| + | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/Parts">Parts</a></li> | ||
| + | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/Basic_Part">Basic Part</a></li> | ||
| + | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/Composite_Part">Composite Part</a></li> | ||
| + | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/Part_Collection">Part Collection</a></li> | ||
| + | </ul> | ||
| + | </li> | ||
<li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/labnotes">Notebook</a></li> | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/labnotes">Notebook</a></li> | ||
<li class="list-item has-sub-nav"> | <li class="list-item has-sub-nav"> | ||
<a>Human Practice</a> | <a>Human Practice</a> | ||
<ul class="sub-nav"> | <ul class="sub-nav"> | ||
| − | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/ | + | <li class="list-item"><a href="https://2015.igem.org/Team:HSNU-TAIPEI/Practices">Overview</a></li> |
<li class="list-item has-sub-nav"> | <li class="list-item has-sub-nav"> | ||
<a>Organization</a> | <a>Organization</a> | ||
cyp1a2 can oxidize the substances that it can metabolism. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. CYP1A2 is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include aflatoxin B1, and acetaminophen.